<DOC>
	<DOCNO>NCT01001130</DOCNO>
	<brief_summary>Non-interventional , open-label , single group , multicentric post-marketing surveillance monitor safety effectiveness AVAMYS nasal spray administer Korean patient accord prescribe information . AVAMYS register trademark GSK group company .</brief_summary>
	<brief_title>Regulatory AVAMYS Nasal Spray PMS</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis , Allergic , Perennial</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<criteria>All subject must satisfy follow criterion . 1 . Subject treat AVAMYS nasal spray first time . 2 . Subject treat due symptom seasonal perennial allergic rhinitis adult child â‰¥2 year . 3 . Subject consider follow PMS protocol investigator . 4 . Subject contactable via telephone . 5 . Subject treat AVAMYS nasal spray accord prescribe information . As consider characteristic observational post marketing surveillance , exclusion criterion strict . All investigator prescribe AVAMYS nasal spray accord prescribe information approve Korea . All subject must satisfy follow criterion . 1 . Subject hypersensitivity ingredient . 2 . As corticosteroid slow heal wound , subject surgery his/her nose recently , sore his/her nose , his/her nose injured , subject use AVAMYS nasal spray his/her nose heal .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>avamys</keyword>
	<keyword>Allergic Rhinitis</keyword>
	<keyword>post marketing surveillance</keyword>
	<keyword>Seasonal Allergic Rhinitis</keyword>
	<keyword>Perennial Allergic Rhinitis ( PAR )</keyword>
</DOC>